Bioreactors Pull Out Some of the Stops
Balancing Bioreactor and Process Parameters Avoids Production Discord and Amplifies Flows
Commercializing Gene Therapies
Using High-Touch Services to Enhance Patient Outcomes
Epitope Mapping Orients Immune Interventions
Before Launching an Immune Intervention, Get the Lay of the Land
What the Top 10 Biopharma CEOs Are Making
Surging Markets Drive Double- and Triple-Digit Percentage Gains for Compensation
For full access to this article login to GEN Select now.
Central Eastern Europe Targets Biotech
Questions Remain on Whether Fledgling Industry Will Find Enough Support to Thrive
- This year’s “BioForum 2011” conference in Lodz, Poland, exposed the good and the bad about Central Eastern Europe’s (CEE) biotech industry. The good news is that CEE is beginning to establish a biotech presence: there are over 200 companies (many of which are small start-ups) in the 10 countries ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.